Lanxess AG LANXESS ORD SHS
Lanxess AG LANXESS ORD SHS/ DE0005470405 /
0H7I
|
24/05/2024 18:13:13
|
Var.
-
|
Volume |
Denaro09:10:02 |
Lettera09:10:02 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
25.49EUR
|
-
|
5,127
Fatturato: 111,884.50 |
25.17Quantità in denaro: 5,000 |
25.72Quantità in lettera: 5,000 |
2.16 bill.EUR |
0.40% |
4.87 |
Descrizione business
LANXESS is a leading specialty chemicals company. The company is currently represented at 58 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World) and FTSE4Good.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Matthias Zachert |
| Consiglio di amministrazione |
| Oliver Stratmann, Dr. Hubert Fink, Frederique van Baarle |
| Consiglio di sorveglianza |
| Dr. Matthias L. Wolfgruber, Hans van Bylen , Dr. Heike Hanagarth , Pamela Knapp , Lawrence A. Rosen , Dr. Rainier van Roessel , Birgit Bierther , Armando Dente , Dr. Hans-Dieter Gerriets , Ralf Sikorski , Iris Schmitz , Manuela Strauch |
Dati aziendali
| Name: |
LANXESS AG |
| Indirizzo: |
Kennedyplatz 1,D-50569 Köln |
| Telefono: |
+49-221-8885-0 |
| Fax: |
- |
| E-mail: |
lanxess-info@lanxess.com
|
| Internet: |
www.lanxess.com |
| Industria: |
Commodities |
| Settore: |
Chemicals |
| Sub settore: |
- |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
37.39% |
| Data dell'IPO: |
31/01/2005 |
Rapporti con gli investitori
| Name: |
Oliver Stratmann |
| IR telefono: |
+49-221-8885-9834 |
| IR Fax: |
+49-221-8885-4944 |
| IR e-mail: |
ir@lanxess.com
|
Company calendar
|
CW 12 | 20/03/2025
Annual Report
|
|
CW 19 | 08/05/2025
Interim Report 1st Quarter/3 Months
|
|
CW 21 | 22/05/2025
General Shareholder Meeting
|
|
CW 33 | 14/08/2025
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 06/11/2025
Interim Report 3rd Quarter/9 Months
|